2 Beaten-Down Consumer Stocks That Could Double in Five Years

Chewy (CHWY) is framed as undervalued at 16x forward P/E despite improving fundamentals: Q1 revenue rose 7.7% to $3.36B, Autoship sales grew 10%+ to 84% of total sales, net adds were ~170k to 21.5M active customers, and adjusted EBITDA margin hit a record 7.5% (+100 bps YoY). Celsius (CELH) is also seen as trading ~46% below its 52-week high, with Q2 revenue up 11% YoY to $818M and retail sales up 31% across tracked channels, supporting a bullish outlook if it sustains double-digit growth and margin expansion.

Analysis

CHWY is the cleaner quality-improvement story. Autoship concentration plus rising order density makes revenue more durable than the market typically credits, and the real upside is not just top-line share gain but lower churn, better fulfillment leverage, and a higher mix of monetized ads/health services that can expand FCF faster than reported sales. That combination can justify a re-rating if margins keep inflecting, but the setup is still execution-dependent because the pet category itself is not a high-beta growth market.

CELH is more timing-sensitive. The business can look weak in reported revenue even while sell-through stays strong, which means the stock may remain vulnerable to quarter-to-quarter narrative shifts until inventory normalizes. The competitive second-order effect is a shelf-space war: sustained share gains should pressure smaller energy brands and MNST facings, while Pepsi’s distribution machine also gains throughput, but the same partner dependence means CELH’s upside can be throttled if shipments are used to manage channel inventory.

Contrarian take: the market may be overpaying for the idea that both names are straightforward compounders. CHWY probably deserves a premium if EBITDA margins keep expanding, but CELH needs independent confirmation from scanner data, not just management commentary, before it deserves a clean long. Falsifiers: CHWY customer growth/Autoship decelerates or EBITDA margin slips back below the current trend; CELH retail sell-through falls toward shipment growth, or international remains too small to matter over the next 2-3 quarters.

Key Decisions for Investors

• Long CHWY on pullbacks, 6-12 month horizon, because the best part of the thesis is operating leverage from loyalty and mix; downside is a de-rate if margin expansion stalls.
• Use CHWY as the higher-conviction long versus CELH; if forced to choose one, CHWY has the cleaner path to multiple expansion over the next 2-4 quarters.
• For CELH, wait for confirmatory scanner-data checks before adding size; if U.S. retail sell-through remains > shipment growth, consider a smaller starter long or call spread into the next earnings window.
• Relative value: long CELH / short MNST only if channel data continues to show share gains at the shelf; otherwise avoid expressing the thesis with leverage because timing noise can dominate for 1-2 quarters.
• Set alerts on CHWY EBITDA margin and active customer growth, and on CELH retail sales versus reported revenue; either breakdown should be treated as a thesis break, not a dip-buy.